Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
3,545 results
  • Pharmacoinformatics and Molecular Docking studies reveal potential novel compounds against Schizophrenia by target SYN II. [Journal Article]
  • CCComb Chem High Throughput Screen 2018 Feb 12
  • Tahir RA, Sehgal SA
  • CONCLUSIONS: It was proposed that Aripiprazole drug and scrutinized compounds have strong binding affinities among the other selected drugs. The reported compounds may use for further analyses in the drug discovery processes and it has been identified as a good human intestinal absorption and non-carcinogenic. The present study provides the structural insights which may be used for further understating of the Schizophrenia therapeutic purposes by targeting SYN II and others inhibitors haunting.
  • Therapeutic drug monitoring of atypical antipsychotics. [Review]
  • PPPsychiatr Pol 2017 Dec 30; 51(6):1059-1077
  • Urban AE, Cubała WJ
  • The paper presents an overview and analysis of the results of research on therapeutic ranges of concentrations and receptor occupancy, mainly D2 receptors, in the treatment with some atypical antipsy...
New Search Next